Clinical Trials Browser

Neoplasms, Risk Reduction Behavior

NCT05853848 2024-10-10

Mammogram Mail- and Phone-based Interventions

Phase NA Completed

14,386 enrolled

Breast

Behavior, Breast Neoplasms, Communication, Risk Reduction Behavior

NCT05834933 2023-08-03

NBCRS

Phase NA Completed

719 enrolled

Breast

Behavior, Breast Neoplasms, Patient Acceptance of Health Care, Health Behavior, Risk Reduction Behavior

NCT04555902 2021-11-15

Evaluation of Mailers Promoting Mammogram Screening

Phase NA Completed

1,342 enrolled

Breast

Behavior, Breast Neoplasms, Communication, Risk Reduction Behavior

NCT04548765 2021-09-24

Evaluation of Letters Promoting Colorectal Cancer Testing

Phase NA Completed

14,644 enrolled

Gastrointestinal

Behavior, Colonic Neoplasms, Communication, Risk Reduction Behavior

NCT04267263 2021-07-26

A Novel Approach to Reducing Adiposity Among Young Men

Phase NA Completed

35 enrolled

EndocrineOther

Cardiovascular Diseases, Obesity, Weight Loss, Multiple Endocrine Neoplasia Type 1, Risk Reduction Behavior

NCT03315286 2019-12-18

Validation of SHADE a Mobile Technology for Monitoring of Ultraviolet Exposure

Phase NA Completed

111 enrolled 13 charts

Dermatologic

Skin Neoplasms, Health Behavior, Risk Reduction Behavior, Keratosis, Actinic

NCT00906321 2017-07-02

Facilitating Web-based Patient Decision Support: Decision About Medication to Lower Breast Cancer Risk

Phase NA Completed

64 enrolled

Risk Reduction Behavior

NCT03118882 2017-04-19

STIVI

Phase NA Completed

1,270 enrolled

BreastGastrointestinal

Body Weight Changes, Breast Neoplasms, Colorectal Neoplasms, Risk Reduction Behavior

Clinical Trials

BRIDGE

Mammogram Mail- and Phone-based Interventions

NBCRS

Evaluation of Mailers Promoting Mammogram Screening

Evaluation of Letters Promoting Colorectal Cancer Testing

A Novel Approach to Reducing Adiposity Among Young Men

Validation of SHADE a Mobile Technology for Monitoring of Ultraviolet Exposure

Facilitating Web-based Patient Decision Support: Decision About Medication to Lower Breast Cancer Risk

STIVI